News

Filter

Current filters:

Merck SeronoOncology

1 to 9 of 37 results

Merck enters lucrative cancer alliance with Pfizer

Merck enters lucrative cancer alliance with Pfizer

17-11-2014

Germany’s Merck KGaA said today that it has entered into a global agreement with US pharma giant Pfizer…

BiotechnologyGermanyLicensingMarkets & MarketingMerck KGaAMerck SeronoMSB0010718COncologyPfizerUSAXalkori

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

Merck Serono links with ICR and Wellcome Trust on anti-cancer drugs

07-10-2014

German life sciences major Merck KGaA says its biopharma division Merck Serono has entered into a co-development…

BiotechnologyGermanyLicensingMerck KGaAMerck SeronoOncologyResearch

Merck Serono on track with pharma strategy

Merck Serono on track with pharma strategy

18-09-2014

Germany’s Merck KGaA says that its biopharmaceutical division - Merck Serono - is well on track with…

ataciceptBiosimilarsFinancialGermanyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearchTH-302

Merck Serono pulls plug on tecemotide in Stage III NSCLC

Merck Serono pulls plug on tecemotide in Stage III NSCLC

12-09-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, is to discontinue the clinical development…

BiotechnologyGermanyMerck SeronoOncologyResearch

Erbitux equal to Avastin in colorectal cancer survival, FIRE-3 study shows

Erbitux equal to Avastin in colorectal cancer survival, FIRE-3 study shows

30-06-2014

Merck Serono, the biotech subsidiary of Germany’s Merck KGaA, has released positive new clinical trial…

AvastinBiotechnologyErbituxMerck KGaAMerck SeronoOncologyResearchRoche

MorphoSys and Merck Serono collaborate on immuno-oncology

MorphoSys and Merck Serono collaborate on immuno-oncology

12-06-2014

German companies MorphoSys and Merck KGaA unit Merck Serono today announced the signing of an agreement…

BiotechnologyCancer therapyHealth Medical PharmaHuman antibody technologiesImmune systemImmunologicalsLeaderLicensingMerck KGaAMerck SeronoMorphoSysOncologyResearch

Merck Serono’s Erbitux to be funded by CDF in England for mCRC

28-02-2014

The UK’s Cancer Drugs Fund (CDF) says that Erbitux (cetuximab) can be used in the first line setting…

ErbituxFinancialHealthcareMerck KGaAMerck SeronoNorthern EuropeOncologyPharmaceuticalUK

1 to 9 of 37 results

COMPANY SPOTLIGHT

Menarini

Back to top